Last reviewed · How we verify
NCT05244785
Health and Nutrition Survey on Shenzhen Children
trial in Nutrition Disorder, Child in 4,500 participants. Completed in 31 March 2022.
28 February 2022
Quick facts
| Lead sponsor | Shenzhen Center for Chronic Disease Control |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 4,500 |
| Start date | 20 October 2021 |
| Primary completion | 28 February 2022 |
| Estimated completion | 31 March 2022 |
| Sites | 1 location across China |
Conditions studied
- Nutrition Disorder, Child — all drugs for Nutrition Disorder, Child →
- Nutrition Disorders in Adolescence — all drugs for Nutrition Disorders in Adolescence →
- Nutritional Deficiency — all drugs for Nutritional Deficiency →
- Nutrition, Healthy — all drugs for Nutrition, Healthy →
Sponsor
Shenzhen Center for Chronic Disease Control
Who can join
Adults 5 to 18, any sex, with Nutrition Disorder, Child or Nutrition Disorders in Adolescence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1. Master and analyze the nutritional health, growth and development status of primary and secondary school students in Shenzhen, and discover the main nutritional health, growth and development problems and influencing factors. 2. Provide basic data and evidence-based basis for the municipal government and related departments to formulate child health policies and measures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05244785
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Shenzhen Center for Chronic Disease Control trials
Trials by the same sponsor.
- NCT04004143 — Micronutrients and Health in Adult Chinese · completed
- NCT04707612 — VDR SNPs & 25OHD Correlated With Dyslipidemia · completed
- NCT03406234 — Observational Study on a Chinese Population · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05244785 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shenzhen Center for Chronic Disease Control
- Last refreshed: 24 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05244785.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing